secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001801170-24-000085
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health receives Nasdaq bid price deficiency notice; has until Sep 30, 2024 to regain compliance
--------------------------------------------------------------------------------

- Received Nasdaq notice on April 2, 2024 for CLOV closing below $1.00 for 30 consecutive business days.
- Company has 180 days, until September 30, 2024, to regain compliance via a $1.00 close for 10 consecutive days.
- Options to cure include a reverse stock split (subject to stockholder approval) or transfer to Nasdaq Capital Market.
- If not compliant by Sep 30, may seek a second 180-day period by moving to Nasdaq Capital Market.
- Failure to regain compliance could lead to delisting; appeal rights available.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000085/0001801170-24-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000085/clov-20240402.htm
  HTML page:      https://secwatch.observer/filing/0001801170-24-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer